APA

Akl H., Badran B. M., Zein N. E., Zein N. E., Bex F., Sotiriou C., Willard-Gallo K. E., Burny A. & Martiat P. (20070928). HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation. : Leukemia.

Chicago

Akl H, Badran B M, Zein N El, Zein N E, Bex F, Sotiriou C, Willard-Gallo K E, Burny A and Martiat P. 20070928. HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation. : Leukemia.

Harvard

Akl H., Badran B. M., Zein N. E., Zein N. E., Bex F., Sotiriou C., Willard-Gallo K. E., Burny A. and Martiat P. (20070928). HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation. : Leukemia.

MLA

Akl H, Badran B M, Zein N El, Zein N E, Bex F, Sotiriou C, Willard-Gallo K E, Burny A and Martiat P. HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation. : Leukemia. 20070928.